This inventor holds 21 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 6 EPO patents, primarily in Biochemical Inhibitors. Top assignees: Pharmakea, Inc., Sabre Therapeutics LLC, Mannkind Corporation. Active years: 2010-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Ventura, CA (US) (2013 - 2016)
- San Marcos, CA (US) (2010 - 2020)
- San Diego, CA (US) (2020 - 2023)
Company Filing History:
11 out of 19 
5 out of 5 
4 out of 286 
Years Active: 2010-2025
Areas of Expertise:
Title: David Gregory Lonergan: Innovator in Pharmaceutical Compounds
Introduction
David Gregory Lonergan, based in Ventura, California, is a notable inventor with an impressive portfolio of 20 patents. His contributions to the field of pharmaceuticals have made significant impacts, particularly in the development of innovative compounds aimed at treating various health conditions.
Latest Patents
Lonergan's latest patents include groundbreaking research on autotaxin inhibitor compounds. These patents describe various compounds that can inhibit autotaxin, along with methods of producing these compounds and pharmaceutical compositions that include them. Furthermore, his work encompasses the development of crystalline forms of a lysyl oxidase-like 2 inhibitor. This patent illustrates the various methods of production and the potential medicinal applications for the treatment of conditions related to LOXL2 activity.
Career Highlights
Throughout his career, David has collaborated with various esteemed institutions, most notably Pharmakea, Inc. and MannKind Corporation. His endeavors in these companies highlight his commitment to advancing pharmaceutical research and innovation. His experience has enabled him to develop valuable intellectual property that contributes significantly to modern medicine.
Collaborations
David has also worked alongside prominent professionals in the field, including John Howard Hutchinson and Martin W Rowbottom. These collaborations have facilitated the exchange of ideas and expertise, leading to the development of pioneering pharmaceutical solutions.
Conclusion
David Gregory Lonergan stands out as an influential inventor in the pharmaceutical arena. His innovative patents and collaborative spirit continue to drive advancements that promise to enhance the treatment of various diseases. His work exemplifies the importance of innovation in improving health outcomes and showcases the potential of patented inventions to transform the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile